Perjeta Regimen Cuts Death Risk by 17% in HER2+ Breast Cancer

Read more

Trixeo Aerosphere Approved in UK as First Inhaled Respiratory Drug with Near-Zero GWP Propellant

Read more

Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP

Read more

Beam Therapeutics’ BEAM-302 Granted RMAT Designation by FDA for AATD Treatment

Read more

Novo Nordisk’s Once-Weekly Sogroya Proves Effective in Children with Growth Disorders

Read more

Amneal and ApiJect Partner to Boost U.S. Sterile BFS Manufacturing Capacity

Read more

HAYA Therapeutics Secures $65M Series A to Advance RNA-Guided Therapies for Chronic Diseases

Read more

Genezen and Optieum Partner to Advance cGMP Manufacturing for Glioblastoma CAR-T Therapy

Read more

Adcentrx’s ADRX-0706 Nectin-4 ADC Earns FDA Fast Track for Advanced Cervical Cancer

Read more

Opus Genetics’ OPGx-LCA5 Gene Therapy Earns FDA RMAT Designation

Read more